Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
NCT05518305
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Stroke
- TIA
- Ischemic Stroke
- Ischemic
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of California, Los Angeles
- Last updated on ClinicalTrials.gov
- June 11, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Ronald Reagan UCLA Medical Center · Los Angeles, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.